2332897-85-3 Usage
Uses
Used in Pharmaceutical Research:
(S)-4-(2,5-difluorophenyl)-2-(3-fluoropyrrolidin-1-yl)-N-(6-isopropylpyridin-3-yl)nicotinamide is used as a research compound for exploring its interaction with specific receptors or enzymes in the body. Its complex structure and potential pharmacological properties make it a promising candidate for drug development in the treatment of neurological or psychiatric disorders.
Used in Drug Development:
In the pharmaceutical industry, (S)-4-(2,5-difluorophenyl)-2-(3-fluoropyrrolidin-1-yl)-N-(6-isopropylpyridin-3-yl)nicotinamide is utilized as a lead compound in the development of new drugs targeting neurological or psychiatric conditions. Its unique structure and potential to modulate specific biological pathways make it a valuable asset in the search for novel therapeutic agents.
Further investigation is necessary to fully understand the biological and pharmacological activity of (S)-4-(2,5-difluorophenyl)-2-(3-fluoropyrrolidin-1-yl)-N-(6-isopropylpyridin-3-yl)nicotinamide and to determine its potential therapeutic uses in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 2332897-85-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,3,3,2,8,9 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2332897-85:
(9*2)+(8*3)+(7*3)+(6*2)+(5*8)+(4*9)+(3*7)+(2*8)+(1*5)=193
193 % 10 = 3
So 2332897-85-3 is a valid CAS Registry Number.
2332897-85-3Relevant academic research and scientific papers
Discovery of novel 4-phenyl-2-(pyrrolidinyl)nicotinamide derivatives as potent Nav1.1 activators
Miyazaki, Tohru,Kawasaki, Masanori,Suzuki, Atsushi,Ito, Yuki,Imanishi, Akio,Maru, Takamitsu,Kawamoto, Tomohiro,Koike, Tatsuki
, p. 815 - 820 (2019/01/30)
The voltage-gated sodium channel, Nav1.1, is predominantly expressed in parvalbumin-positive fast spiking interneurons and has been genetically linked to Dravet syndrome. Starting from a high throughput screening hit isoxazole derivative 5, mod
